The CIS insulin market was valued at USD 3.05 billion in 2023 and is anticipated to reach USD 4.67 billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. The market growth is primarily driven by the rising prevalence of diabetes, lifestyle changes leading to obesity, and the growing awareness regarding effective diabetes management. Increasing investments in research and development,...

"Executive Summary Inhalable Insulin Market Value, Size, Share and Projections CAGR Value : The global inhalable insulin market size was valued at USD 630 million in 2024 and is expected to reach USD 1,476.10 million by 2032, at a CAGR of 11.23% during the forecast period.   The top notch Inhalable Insulin Market report explains current and...

The global insulin market is expected to reach USD 23.20 billion by 2030, expanding at a CAGR of 1.5% during the forecast period, according to a new report by Grand View Research, Inc. It is an oligopolistic space dominated by companies such as Novo Nordisk A/S, Sanofi, and Eli Lilly and Company. The increasing incidence of diabetes and formulation advancements in insulin delivery are...

The global insulin market size was estimated at USD 20.35 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2022 to 2030.  The insulin market is witnessing growth due to factors such as the increasing incidence of diabetes and formulation advancements. However, the increasing prescription of drugs such as GLP-1 RAs to treat type 2...